Shopping Cart
- Remove All
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $43 | In Stock | |
50 mg | $68 | In Stock | |
100 mg | $113 | In Stock | |
200 mg | $146 | In Stock | |
500 mg | $242 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | Pimavanserin tartrate (Nuplazid) is an effective and specific serotonin 5-HT2A inverse agonist (pIC50: 8.73), used in the therapy of psychosis associated with Parkinson's disease. |
In vivo | In rats, Pimavanserin (3 mg/kg, p.o.) attenuates DOI-induced head twitches. In mice, Pimavanserin (3 mg/kg, p.o.) significantly attenuates MK-801-induced hyperactivity. [1] In a rat model of parkinsonian tremor, Pimavanserin (40 mg/kg, i.p.) produces a significant overall reduction of tacrine-induced tremulous jaw movements. [2] |
Alias | ACP-103, ACP-103 tartrate, Nuplazid, Pimavanserin |
Molecular Weight | 1005.2 |
Formula | C50H68F2N6O4·C4H6O6 |
Cas No. | 706782-28-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | ||||||||||||||||||||||||||||||||||||||||
Solubility Information | Ethanol: 93 mg/mL (92.5 mM) DMSO: 60 mg/mL (59.69 mM) H2O: 92 mg/mL (91.5 mM) | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.